These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 32707820)

  • 21. Whole-genome landscape of adult T-cell leukemia/lymphoma.
    Kogure Y; Kameda T; Koya J; Yoshimitsu M; Nosaka K; Yasunaga JI; Imaizumi Y; Watanabe M; Saito Y; Ito Y; McClure MB; Tabata M; Shingaki S; Yoshifuji K; Chiba K; Okada A; Kakiuchi N; Nannya Y; Kamiunten A; Tahira Y; Akizuki K; Sekine M; Shide K; Hidaka T; Kubuki Y; Kitanaka A; Hidaka M; Nakano N; Utsunomiya A; Sica RA; Acuna-Villaorduna A; Janakiram M; Shah U; Ramos JC; Shibata T; Takeuchi K; Takaori-Kondo A; Miyazaki Y; Matsuoka M; Ishitsuka K; Shiraishi Y; Miyano S; Ogawa S; Ye BH; Shimoda K; Kataoka K
    Blood; 2022 Feb; 139(7):967-982. PubMed ID: 34695199
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Resistance of Cancer Cells to Targeted Therapies Through the Activation of Compensating Signaling Loops.
    von Manstein V; Yang CM; Richter D; Delis N; Vafaizadeh V; Groner B
    Curr Signal Transduct Ther; 2013 Dec; 8(3):193-202. PubMed ID: 25045345
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multiple signaling pathways induced by granulocyte colony-stimulating factor involving activation of JAKs, STAT5, and/or STAT3 are required for regulation of three distinct classes of immediate early genes.
    Tian SS; Tapley P; Sincich C; Stein RB; Rosen J; Lamb P
    Blood; 1996 Dec; 88(12):4435-44. PubMed ID: 8977235
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expressional STAT3/STAT5 Ratio is an Independent Prognostic Marker in Colon Carcinoma.
    Klupp F; Diers J; Kahlert C; Neumann L; Halama N; Franz C; Schmidt T; Lasitschka F; Warth A; Weitz J; Koch M; Schneider M; Ulrich A
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1548-55. PubMed ID: 25773877
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selective activation of STAT3 and STAT5 dictates the fate of myeloid progenitor cells.
    Zhang M; Meng Y; Ying Y; Zhou P; Zhang S; Fang Y; Yao Y; Li D
    Cell Death Discov; 2023 Jul; 9(1):274. PubMed ID: 37507383
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Balancing STAT Activity as a Therapeutic Strategy.
    Polak KL; Chernosky NM; Smigiel JM; Tamagno I; Jackson MW
    Cancers (Basel); 2019 Nov; 11(11):. PubMed ID: 31684144
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A preferential role for STAT5, not constitutively active STAT3, in promoting survival of a human lymphoid tumor.
    Nagy ZS; Rui H; Stepkowski SM; Karras J; Kirken RA
    J Immunol; 2006 Oct; 177(8):5032-40. PubMed ID: 17015686
    [TBL] [Abstract][Full Text] [Related]  

  • 28. STAT5 Represses a STAT3-Independent Th17-like Program during Th9 Cell Differentiation.
    Canaria DA; Yan B; Clare MG; Zhang Z; Taylor GA; Boone DL; Kazemian M; Olson MR
    J Immunol; 2021 Sep; 207(5):1265-1274. PubMed ID: 34348976
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Withacnistin inhibits recruitment of STAT3 and STAT5 to growth factor and cytokine receptors and induces regression of breast tumours.
    Zhang X; Blaskovich MA; Forinash KD; Sebti SM
    Br J Cancer; 2014 Aug; 111(5):894-902. PubMed ID: 24983364
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Constitutive activation of STAT3 and STAT5 is present in the majority of nasopharyngeal carcinoma and correlates with better prognosis.
    Hsiao JR; Jin YT; Tsai ST; Shiau AL; Wu CL; Su WC
    Br J Cancer; 2003 Jul; 89(2):344-9. PubMed ID: 12865928
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of DNA methyltransferase induces G2 cell cycle arrest and apoptosis in human colorectal cancer cells via inhibition of JAK2/STAT3/STAT5 signalling.
    Xiong H; Chen ZF; Liang QC; Du W; Chen HM; Su WY; Chen GQ; Han ZG; Fang JY
    J Cell Mol Med; 2009 Sep; 13(9B):3668-79. PubMed ID: 20196786
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IL-6 activates STAT5 in T cells.
    Tormo AJ; Letellier MC; Sharma M; Elson G; Crabé S; Gauchat JF
    Cytokine; 2012 Nov; 60(2):575-82. PubMed ID: 22854263
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ectopic PD-L1 expression in JAK2 (V617F) myeloproliferative neoplasm patients is mediated via increased activation of STAT3 and STAT5.
    Guru SA; Sumi MP; Mir R; Waza AA; Bhat MA; Zuberi M; Lali P; Saxena A
    Hum Cell; 2020 Oct; 33(4):1099-1111. PubMed ID: 32430672
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aberrantly low STAT3 and STAT5 responses are associated with poor outcome and an inflammatory gene expression signature in pediatric acute myeloid leukemia.
    Narayanan P; Man TK; Gerbing RB; Ries R; Stevens AM; Wang YC; Long X; Gamis AS; Cooper T; Meshinchi S; Alonzo TA; Redell MS
    Clin Transl Oncol; 2021 Oct; 23(10):2141-2154. PubMed ID: 33948920
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Constitutive STAT5 phosphorylation in CD34+ cells of patients with primary myelofibrosis: Correlation with driver mutation status and disease severity.
    Abbà C; Campanelli R; Catarsi P; Villani L; Abbonante V; Sesta MA; Barosi G; Rosti V; Massa M
    PLoS One; 2019; 14(8):e0220189. PubMed ID: 31369569
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pan-cancer assessment of mutational landscape in intrinsically disordered hotspots reveals potential driver genes.
    Zou H; Pan T; Gao Y; Chen R; Li S; Guo J; Tian Z; Xu G; Xu J; Ma Y; Li Y
    Nucleic Acids Res; 2022 May; 50(9):e49. PubMed ID: 35061901
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Non-coding cancer driver candidates identified with a sample- and position-specific model of the somatic mutation rate.
    Juul M; Bertl J; Guo Q; Nielsen MM; Świtnicki M; Hornshøj H; Madsen T; Hobolth A; Pedersen JS
    Elife; 2017 Mar; 6():. PubMed ID: 28362259
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Jak3, STAT3, and STAT5 inhibit expression of miR-22, a novel tumor suppressor microRNA, in cutaneous T-Cell lymphoma.
    Sibbesen NA; Kopp KL; Litvinov IV; Jønson L; Willerslev-Olsen A; Fredholm S; Petersen DL; Nastasi C; Krejsgaard T; Lindahl LM; Gniadecki R; Mongan NP; Sasseville D; Wasik MA; Iversen L; Bonefeld CM; Geisler C; Woetmann A; Odum N
    Oncotarget; 2015 Aug; 6(24):20555-69. PubMed ID: 26244872
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of human STAT5-dependent gene regulatory elements based on interspecies homology.
    Nelson EA; Walker SR; Li W; Liu XS; Frank DA
    J Biol Chem; 2006 Sep; 281(36):26216-24. PubMed ID: 16840779
    [TBL] [Abstract][Full Text] [Related]  

  • 40. STAT3 Activity and Function in Cancer: Modulation by STAT5 and miR-146b.
    Walker SR; Xiang M; Frank DA
    Cancers (Basel); 2014 Apr; 6(2):958-68. PubMed ID: 24762632
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.